Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases.

ESMO open·2024
Same author

The 2023 Practitioner's Toolkit for Managing Menopause.

Climacteric : the journal of the International Menopause Society·2023
Same author

A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats.

Psychopharmacology·2021
Same author

Uncommon cause of acute abdomen in adult patient.

Acta gastro-enterologica Belgica·2020
Same author

Empty pelvis syndrome: the use of breast prosthesis in the prevention of complications.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2019
Same author

A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms.

Psychopharmacology·2019

Related Experiment Video

Updated: Jul 29, 2026

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

Quantifying drug-drug interactions in pharmaco-EEG.

M J Barbanoj1, R M Antonijoan, J Riba

  • 1Centre d'lnvestigació de Medicaments, Institut de Recerca, Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau. mbarbanoj@santpau.es

Clinical EEG and Neuroscience
|June 1, 2006
PubMed
Summary

Drug interactions occur when medications modify each other's effects, impacting magnitude or duration. Understanding pharmacodynamic interactions is crucial for predicting drug responses and ensuring patient safety.

More Related Videos

Computer-based Multitaper Spectrogram Program for Electroencephalographic Data
04:13

Computer-based Multitaper Spectrogram Program for Electroencephalographic Data

Published on: November 13, 2019

A Protocol For Uncovering Neural Mechanisms Of Neurotherapeutic Effects On Electroencephalography Using The Human Neocortical Neurosolver
07:47

A Protocol For Uncovering Neural Mechanisms Of Neurotherapeutic Effects On Electroencephalography Using The Human Neocortical Neurosolver

Published on: May 19, 2026

Related Experiment Videos

Last Updated: Jul 29, 2026

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

Computer-based Multitaper Spectrogram Program for Electroencephalographic Data
04:13

Computer-based Multitaper Spectrogram Program for Electroencephalographic Data

Published on: November 13, 2019

A Protocol For Uncovering Neural Mechanisms Of Neurotherapeutic Effects On Electroencephalography Using The Human Neocortical Neurosolver
07:47

A Protocol For Uncovering Neural Mechanisms Of Neurotherapeutic Effects On Electroencephalography Using The Human Neocortical Neurosolver

Published on: May 19, 2026

Area of Science:

  • Pharmacology
  • Neuroscience

Background:

  • Drug interactions modify pharmacological effects, often due to co-administration of multiple drugs.
  • Interactions can occur on pharmaceutical, pharmacokinetic, or pharmacodynamic levels.
  • Pharmacodynamic interactions involve alterations at the site of drug action.

Purpose of the Study:

  • To explore the multifaceted nature of drug interactions, focusing on pharmacodynamic mechanisms.
  • To categorize psychotropic drug interactions based on study objectives (safety, pharmacological, neuro-physiological).
  • To highlight methodological considerations and address unresolved questions in drug interaction research.

Main Methods:

  • Review of drug interaction mechanisms, including pharmaceutical, pharmacokinetic, and pharmacodynamic bases.
  • Analysis of pharmacodynamic interactions involving drugs, metabolites, enantiomers, tolerance, and sensitization.
  • Classification of psychotropic drug interactions using quantitative pharmaco-electroencephalography (EEG).

Main Results:

  • Pharmacodynamic interactions can lead to antagonism or synergism at various biological levels (receptor, intraneuronal, interneuronal).
  • Examples illustrate interactions involving specific drugs, metabolites, and enantiomers.
  • Quantitative pharmaco-EEG provides a framework for assessing psychotropic drug interactions.

Conclusions:

  • Pharmacodynamic interactions are complex, involving multiple mechanisms and levels of action.
  • Methodological rigor, including drug concentrations and dose-response relationships, is essential for accurate interaction assessment.
  • Further research is needed to address complex drug interactions and their clinical implications.